Literature DB >> 9351065

National Kidney Foundation: Dialysis Outcome Quality Initiative--development of methodology for clinical practice guidelines.

N Levin1, G Eknoyan, M Pipp, E Steinberg.   

Abstract

BACKGROUND: The NKF-DOQI (National Kidney Foundation--Dialysis Outcomes Quality Initiative) began in March 1995 with the following objectives: To improve end-stage renal disease (ESRF) patient survival, to reduce patient morbidity, to increase efficiency of care, and to improve quality of life for ESRF patients.
METHODS: The development of the NKF-DOQI Clinical Practice Guidelines focused on haemodialysis adequacy, peritoneal dialysis adequacy, vascular access, and anaemia. Principles guiding the methodology included scientific and methodological rigour, interdisciplinary approach, independence of the Work Groups, and an open review process. Unique features of this evidence-based guideline development process included the use of mock guidelines and rationales to guide the literature research, and an unprecedented three-stage review process.
RESULTS: Work Groups reviewed more than 11,000 articles. A total of 114 clinical practice guidelines were developed by the Work Groups; these have been reviewed by more than 1200 professionals and patients.
CONCLUSION: The NKF-DOQI Clinical Practice Guidelines has been a unifying effort for the entire renal community. The guidelines are an important step in the process of improving the quality of dialysis practice and improving ESRF patient outcomes. Priorities for implementation of the guidelines include education of ESRF professionals and patients, working with providers and insurers to encourage compliance, and follow-up evaluation of patient outcomes to quantify compliance results.

Entities:  

Mesh:

Year:  1997        PMID: 9351065     DOI: 10.1093/ndt/12.10.2060

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

Review 1.  Quality Measures for Dialysis: Time for a Balanced Scorecard.

Authors:  Alan S Kliger
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-27       Impact factor: 8.237

2.  Achievements in CKD-MBD guidelines targets: is there a progress in the implementation practice?

Authors:  G Spasovski; V Zdravkovska; M Zabzun; R Antarorov; K Ivanovski; P Janakievska; J Neskovski; E Karceva-Sarajlia; B Panova; T Petrovska; L Zulbeari; J Masin-Spasovska; N Taleska-Matovska; S Gelev
Journal:  Int Urol Nephrol       Date:  2011-12-16       Impact factor: 2.370

3.  Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients.

Authors:  Robert Provenzano; James Tumlin; Raja Zabaneh; James Chou; Stefan Hemmerich; Thomas B Neff; K-H Peony Yu
Journal:  J Clin Pharmacol       Date:  2020-06-30       Impact factor: 3.126

4.  Establishing the criterion validity of self-report measures of adherence in hemodialysis through associations with clinical biomarkers: A systematic review and meta-analysis.

Authors:  Helena Sousa; Oscar Ribeiro; Elísio Costa; Alan Jay Christensen; Daniela Figueiredo
Journal:  PLoS One       Date:  2022-10-18       Impact factor: 3.752

5.  Imaging of Patients with Complex Hemodialysis Arterio-Venous Fistulas using Time-Resolved Dynamic CT Angiography: Comparison with Duplex Ultrasound.

Authors:  Mathias Meyer; Nicole Geiger; Urs Benck; Daniela Rose; Sonja Sudarski; Melissa M Ong; Stefan O Schoenberg; Thomas Henzler
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.